Cyclacel Pharmaceuticals
CYCC
CYCC
29 hedge funds and large institutions have $29.2M invested in Cyclacel Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
Holders
29
Holders Change
+18
Holders Change %
+163.64%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
4
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SFM
1
Sphera Funds Management
Tel Aviv,
Israel
|
$3.61M |
| 2 |
JGC
2
J. Goldman & Co
New York
|
$2.54M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$2.09M |
| 4 |
TLP
4
Tri Locum Partners
New York
|
$2.09M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$2.13M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VFA
26
Valeo Financial Advisors
Carmel,
Indiana
| $32K | +$32K | +1 | New |
|
27
Wells Fargo
San Francisco,
California
| $25K | +$25K | +1 | New |
|
28
UBS Group
Zurich,
Switzerland
| $17K | +$17K | +1 | New |
|
|
FDCDDQ
29
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $14.2K | – | – | – |
|
30
Bank of America
Charlotte,
North Carolina
| $7K | – | – | – |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| $4K | -$1K | – | – |
|
|
RE
32
RBC Europe
London,
United Kingdom
| $1.98K | -$2.17K | – | – |
|
|
CC
33
Commodore Capital
New York
| – | -$2.07M | -74 | Closed |
|
|
ACP
34
Acuta Capital Partners
Redwood City,
California
| – | -$1.17M | -42 | Closed |
|
|
ASN
35
Advisory Services Network
Atlanta,
Georgia
| – | -$11K | – | – |
|